$AKRO $ETNB from a very respected analyst- F4 highest unmet need Large market (1M+ prevalent population just in the U.S. and growing). 300-400K F4 patients may already be under the care of specialists (per estimates from Intercept from back in 2018-2019)
#AKRO #ETNB